ARCHIVES

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

No Benefit For Radiation For Early Stage Disease Spread To Only One Node

March 26, 2010

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

NCI Won’t Recognize Wolmark Wile NSABP is Plaintiff In Suit

November 18, 1994